Johnson & Johnson

JNJ · CIK 0000200406

19 fiscal years · 68 SEC filings · every number carries its receipt

Revenue (FY)

$94.19B6.0%

FY2025

Net income (FY)

$26.80B90.6%

FY2025

Free cash flow (FY)

$19.70B0.7%

FY2025

Diluted EPS (FY)

$11.0390.5%

FY2025

The story, charted

The shape of the business

FY2007–FY2025 · hover any year for its receipt

Revenue & net incomeRevenueNet income

revenue 1.5× since FY2007 · net margin 21.7% → 28.5%

MarginsNet marginFCF margin

FY2025: net 28.5% · free cash flow 20.9% of revenue

Cash engineOperating cash flowFree cash flow

FY2025: $24.53B operating cash − $4.83B capex = $19.70B free cash flow

Returns on capitalReturn on equityReturn on assets

return on equity 24% (FY2010) → 33% (FY2025) · on assets 13.5%

Balance sheetLiabilitiesEquity

FY2025: $199.21B assets · $117.67B liabilities · $81.54B equity

The receipts

Financial statements

Annual Quarterly (as reported)

USD in millions except per-share and share counts. Every value links to the filing it came from — hover for the us-gaap tag, click for the 10-K/10-Q on sec.gov.

USD millions	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014
Revenue	94,193	88,821	85,159	79,990	78,740	82,584	82,059	81,581	76,450	71,890	70,074	74,331
Net income	26,804	14,066	35,153	17,941	20,878	14,714	15,119	15,297	1,300	16,540	15,409	16,323
Diluted EPS	11.03	5.79	13.72	6.73	7.81	5.51	5.63	5.61	0.47	5.93	5.48	5.70
Diluted shares	2,429	2,429	2,560	2,664	2,674	2,671	2,684	2,729	2,745	2,789	2,813	2,864
Operating cash flow	24,530	24,266	22,791	21,194	23,410	23,536	23,416	22,201	21,056	18,767	19,569	18,710
Capital expenditures	4,832	4,424	4,543	4,009	3,652	3,347	3,498	3,670	3,279	3,226	3,463	3,714
Free cash flow	19,698	19,842	18,248	17,185	19,758	20,189	19,918	18,531	17,777	15,541	16,106	14,996
Cash & equivalents	19,709	24,105	21,859	12,889	14,487	13,985	17,305	18,107	17,824	18,972	13,732	14,523
Total assets	199,210	180,104	167,558	187,378	182,018	174,894	157,728	152,954	157,303	141,208	133,411	130,358
Total liabilities	117,666	108,614	98,784	110,574	107,995	111,616	98,257	93,202	97,143	70,790	62,261	60,606
Shareholders' equity	81,544	71,490	68,774	76,804	74,023	63,278	59,471	59,752	60,160	70,418	71,150	69,752

Figures as reported in SEC filings, normalized by stonks with the tag mapping shown on hover; missing tags render as “—”, never as zero. Free cash flow is derived (operating cash flow − capex) with both parents recorded in its lineage. See methodology.